341 related articles for article (PubMed ID: 19306847)
21. Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Acs P; Komoly S
Ideggyogy Sz; 2012 Jul; 65(7-8):266-70. PubMed ID: 23074847
[TBL] [Abstract][Full Text] [Related]
22. The cuprizone model: regional heterogeneity of pathology.
Wergeland S; Torkildsen Ø; Myhr KM; Mørk SJ; Bø L
APMIS; 2012 Aug; 120(8):648-57. PubMed ID: 22779688
[TBL] [Abstract][Full Text] [Related]
23. Cuprizone treatment induces demyelination and astrocytosis in the mouse hippocampus.
Norkute A; Hieble A; Braun A; Johann S; Clarner T; Baumgartner W; Beyer C; Kipp M
J Neurosci Res; 2009 May; 87(6):1343-55. PubMed ID: 19021291
[TBL] [Abstract][Full Text] [Related]
24. Effects of acute and repeated exposure to lipopolysaccharide on cytokine and corticosterone production during remyelination.
Urbach-Ross D; Kusnecov AW
Brain Behav Immun; 2007 Oct; 21(7):962-74. PubMed ID: 17490854
[TBL] [Abstract][Full Text] [Related]
25. White matter changes in schizophrenia: evidence for myelin-related dysfunction.
Davis KL; Stewart DG; Friedman JI; Buchsbaum M; Harvey PD; Hof PR; Buxbaum J; Haroutunian V
Arch Gen Psychiatry; 2003 May; 60(5):443-56. PubMed ID: 12742865
[TBL] [Abstract][Full Text] [Related]
26. Gene expression in brain during cuprizone-induced demyelination and remyelination.
Morell P; Barrett CV; Mason JL; Toews AD; Hostettler JD; Knapp GW; Matsushima GK
Mol Cell Neurosci; 1998 Nov; 12(4-5):220-7. PubMed ID: 9828087
[TBL] [Abstract][Full Text] [Related]
27. Ultrastructural abnormalities and loss of myelinated fibers in the corpus callosum of demyelinated mice induced by cuprizone.
Xiu Y; Cheng GH; Peng C; Wang Y; Li YD; Chao FL; Tang Y
J Neurosci Res; 2017 Aug; 95(8):1677-1689. PubMed ID: 27935632
[TBL] [Abstract][Full Text] [Related]
28. Differential changes in axonal conduction following CNS demyelination in two mouse models.
Bando Y; Takakusaki K; Ito S; Terayama R; Kashiwayanagi M; Yoshida S
Eur J Neurosci; 2008 Nov; 28(9):1731-42. PubMed ID: 18973589
[TBL] [Abstract][Full Text] [Related]
29. Adult CNP::EGFP transgenic mouse shows pronounced hypomyelination and an increased vulnerability to cuprizone-induced demyelination.
Millet V; Marder M; Pasquini LA
Exp Neurol; 2012 Jan; 233(1):490-504. PubMed ID: 22155618
[TBL] [Abstract][Full Text] [Related]
30. Arecoline attenuates memory impairment and demyelination in a cuprizone-induced mouse model of schizophrenia.
Xu Z; Adilijiang A; Wang W; You P; Lin D; Li X; He J
Neuroreport; 2019 Jan; 30(2):134-138. PubMed ID: 30571667
[TBL] [Abstract][Full Text] [Related]
31. Myelin debris regulates inflammatory responses in an experimental demyelination animal model and multiple sclerosis lesions.
Clarner T; Diederichs F; Berger K; Denecke B; Gan L; van der Valk P; Beyer C; Amor S; Kipp M
Glia; 2012 Oct; 60(10):1468-80. PubMed ID: 22689449
[TBL] [Abstract][Full Text] [Related]
32. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period.
Zhang M; Zhan XL; Ma ZY; Chen XS; Cai QY; Yao ZX
Exp Biol Med (Maywood); 2015 Sep; 240(9):1183-96. PubMed ID: 25577802
[TBL] [Abstract][Full Text] [Related]
33. p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice.
Copray JC; Küst BM; Mantingh-Otter I; Boddeke HW
Neuropathol Appl Neurobiol; 2005 Dec; 31(6):600-9. PubMed ID: 16281908
[TBL] [Abstract][Full Text] [Related]
34. Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice.
Makinodan M; Yamauchi T; Tatsumi K; Okuda H; Takeda T; Kiuchi K; Sadamatsu M; Wanaka A; Kishimoto T
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Aug; 33(6):978-85. PubMed ID: 19446597
[TBL] [Abstract][Full Text] [Related]
35. Dynamic expression of Cx47 in mouse brain development and in the cuprizone model of myelin plasticity.
Parenti R; Cicirata F; Zappalà A; Catania A; La Delia F; Cicirata V; Tress O; Willecke K
Glia; 2010 Oct; 58(13):1594-609. PubMed ID: 20578039
[TBL] [Abstract][Full Text] [Related]
36. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
[TBL] [Abstract][Full Text] [Related]
37. Partial inhibition of proteasome activity enhances remyelination after cuprizone-induced demyelination.
Millet V; Moiola CP; Pasquini JM; Soto EF; Pasquini LA
Exp Neurol; 2009 Jun; 217(2):282-96. PubMed ID: 19303006
[TBL] [Abstract][Full Text] [Related]
38. Leukemia inhibitory factor signaling modulates both central nervous system demyelination and myelin repair.
Marriott MP; Emery B; Cate HS; Binder MD; Kemper D; Wu Q; Kolbe S; Gordon IR; Wang H; Egan G; Murray S; Butzkueven H; Kilpatrick TJ
Glia; 2008 Apr; 56(6):686-98. PubMed ID: 18293407
[TBL] [Abstract][Full Text] [Related]
39. Distribution of oligodendrocyte loss and mitochondrial toxicity in the cuprizone-induced experimental demyelination model.
Acs P; Selak MA; Komoly S; Kalman B
J Neuroimmunol; 2013 Sep; 262(1-2):128-31. PubMed ID: 23890807
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging and histological evidence for the blockade of cuprizone-induced demyelination in C57BL/6 mice.
Chandran P; Upadhyay J; Markosyan S; Lisowski A; Buck W; Chin CL; Fox G; Luo F; Day M
Neuroscience; 2012 Jan; 202():446-53. PubMed ID: 22119061
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
